Bernstein Karen 4/A
4/A · Ovid Therapeutics Inc. · Filed Aug 1, 2019
Insider Transaction Report
Form 4/AAmended
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-10+5,813→ 5,813 totalExercise: $1.65Exp: 2029-06-09→ Common Stock (5,813 underlying)
Footnotes (2)
- [F1]This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019.
- [F2]The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date.